TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Brief Intervention for Co-occurring Pain and Distress in Primary Care
Brief Summary: The purpose of this research study is to investigate potential benefits of a behavioral intervention for co-occurring chronic pain and distress that is delivered in a primary care clinic.


Options:
A: Arm Label: problem solving therapy + Behavioral Treatment of Insomnia; Type: EXPERIMENTAL; Interventions: Behavioral: Problem Solving therapy and Brief Behavioral Treatment of Insomnia | Arm Label: Enhanced Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Problem Solving therapy and Brief Behavioral Treatment of Insomnia; Assigned to Arm(s): problem solving therapy + Behavioral Treatment of Insomnia
B: Arm Label: Accountable Condition- 8 clinics; Type: EXPERIMENTAL; Interventions: Behavioral: Accountable Condition | Arm Label: Control Condition- 8 clinics; Type: EXPERIMENTAL; Interventions: Behavioral: Control Condition | Intervention Type: BEHAVIORAL; Name: Accountable Condition; Assigned to Arm(s): Accountable Condition- 8 clinics | Intervention Type: BEHAVIORAL; Name: Control Condition; Assigned to Arm(s): Control Condition- 8 clinics
C: Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Psychotherapy | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Psychotherapy; Assigned to Arm(s): Intervention Group
D: Arm Label: MFG-delivered by trained family peers; Type: EXPERIMENTAL; Interventions: Behavioral: MFG | Arm Label: MFG-delivered by CHWs; Type: EXPERIMENTAL; Interventions: Behavioral: MFG | Arm Label: Bolstered care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: MFG; Assigned to Arm(s): MFG-delivered by CHWs, MFG-delivered by trained family peers

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Recovering Together: Building Resiliency in Dyads of Patients Admitted to the Neuroscience Intensive Care Unit (NICU) and Their Caregivers
Brief Summary: The investigators will compare a dyadic intervention (Recovering Together) with an attention placebo educational control in dyads of patients with acute neurological illnesses and their caregivers at risk for chronic emotional distress. The primary aim of this study is to determine the feasibility, credibility, and satisfaction with Recovering Together. The second aim is to show proof of concept for sustained improvement in emotional distress, post traumatic stress (PTS), resiliency and interpersonal communication outcomes in patients and caregivers.


Options:
A: Arm Label: USUAL; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: USUAL | Arm Label: PEER; Type: EXPERIMENTAL; Interventions: Behavioral: PEER, Behavioral: USUAL | Intervention Type: BEHAVIORAL; Name: PEER; Assigned to Arm(s): PEER | Intervention Type: BEHAVIORAL; Name: USUAL; Assigned to Arm(s): PEER, USUAL
B: Arm Label: Recovering Together; Type: EXPERIMENTAL; Interventions: Behavioral: Recovering Together | Arm Label: Health Education; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Recovering Together; Assigned to Arm(s): Recovering Together
C: Arm Label: In-person behavioral intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Brief pleasurable events/behavioral therapy | Arm Label: Telephone behavioral intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Brief pleasurable events/behavioral therapy | Arm Label: Standard care; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard care | Intervention Type: BEHAVIORAL; Name: Brief pleasurable events/behavioral therapy; Assigned to Arm(s): In-person behavioral intervention, Telephone behavioral intervention | Intervention Type: OTHER; Name: Standard care; Assigned to Arm(s): Standard care
D: Arm Label: intravenous tissue plasminogen activator; Type: EXPERIMENTAL; Interventions: Drug: Alteplase | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Alteplase; Assigned to Arm(s): intravenous tissue plasminogen activator | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Desmopressin for Reversal of Antiplatelet Drugs in Stroke Due to Haemorrhage (DASH)
Brief Summary: Haemorrhagic stroke, an emergency caused by bleeding in the brain, often leads to death or long-term disability. A quarter of these patients are taking blood-thinning drugs (antiplatelet drugs, such as aspirin) because they are at risk of a heart attack or ischaemic stroke. Patients taking these drugs are more likely to die or be disabled if they have a haemorrhagic stroke. At present, there is no effective treatment for reversing their effects. Desmopressin is a drug which may reverse the effects of antiplatelet drugs and stop bleeding. The investigators would like to run a large randomised trial to see if Desmopressin can reduce the number of people who die or are disabled after haemorrhagic stroke.


Options:
A: Arm Label: Tranexamic Acid; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tranexamic Acid | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Tranexamic Acid; Assigned to Arm(s): Tranexamic Acid | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Group 1-Recombinant activated factor VII; Type: ACTIVE_COMPARATOR; Interventions: Drug: recombinant activated factor VII | Arm Label: Group 2 - Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Arm Label: Group 3 - Observation Only Arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: recombinant activated factor VII; Assigned to Arm(s): Group 1-Recombinant activated factor VII | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Group 2 - Placebo
C: Arm Label: Recombinant Activated Factor VII (rFVIIa); Type: ACTIVE_COMPARATOR; Interventions: Biological: Recombinant Activated Factor VII (rFVIIa) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: Recombinant Activated Factor VII (rFVIIa); Assigned to Arm(s): Recombinant Activated Factor VII (rFVIIa) | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Drug: Desmopressin Injection | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Drug: Normal saline | Intervention Type: DRUG; Name: Desmopressin Injection; Assigned to Arm(s): Intervention | Intervention Type: DRUG; Name: Normal saline; Assigned to Arm(s): Control

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pulmonary Rehabilitation Innovation and Microbiota in Exacerbations of COPD
Brief Summary: PRIME goal is to early detect and treat acute exacerbations of chronic obstructive pulmonary disease (AECOPD). This is important since COPD accelerates aging and represents major burden worldwide and in Portugal, mainly due to its frequent AECOPD. Pulmonary rehabilitation (PR) is an effective strategy of its management but it is scarce. When AECOPD are early detected and treated, it optimizes patients' outcomes and reduces the burden of COPD, especially if PR is used. However, up to date, there is no model to predict AECOPD for clinical practice. The lung microbiota shows promise to overcome this barrier and inform on COPD trajectory and will be investigated. In addition, despite of most AECOPD being managed in the community, PR is mainly available in hospitals and less than 1% of patients are having access. Thus, community-based PR will be implemented and a clinical decision tool developed for prioritizing who will most benefit from PR, enhancing evidence-based access to PR.


Options:
A: Arm Label: Intervention; Type: ACTIVE_COMPARATOR; Interventions: Other: Active implementation of a guideline for chronic disease | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: External control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Active implementation of a guideline for chronic disease; Assigned to Arm(s): Intervention
B: Arm Label: COPD patients; Type: N/A; Interventions: N/A
C: Arm Label: Pulmonary rehabilitation; Type: EXPERIMENTAL; Interventions: Other: Pulmonary rehabilitation | Intervention Type: OTHER; Name: Pulmonary rehabilitation; Assigned to Arm(s): Pulmonary rehabilitation
D: Arm Label: Usual information policy; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Antibiotic therapy guidelines; Type: OTHER; Interventions: Other: Mailing of antibiotic therapy guidelines to the sentinel physicians | Intervention Type: OTHER; Name: Mailing of antibiotic therapy guidelines to the sentinel physicians; Assigned to Arm(s): Antibiotic therapy guidelines

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Preventing Risky Drinking and PTSD After Sexual Assault: A Web-Based Intervention
Brief Summary: Sexual assault victimization is a common and particularly harmful form of trauma that is associated with increased risk for high-risk drinking and other conditions of public health concern, such as PTSD. Given evidence that sexual assault survivors who have low social support or receive negative social reactions to sexual assault disclosure are more likely to experience PTSD and drinking problems, improving social support is a novel target for intervention. The proposed study will attempt to prevent the onset of high-risk drinking and PTSD in sexual assault survivors by developing and testing a web-based early intervention aimed at increasing contact with social supporters and mitigating the harm of negative social reactions; ultimately, results will contribute to advancing the field's understanding of the potential for social support to mitigate the harm of trauma.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: App-based intervention | Arm Label: Assessment-only control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: App-based intervention; Assigned to Arm(s): Intervention
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Prolonged Exposure | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Present Centered Therapy | Intervention Type: PROCEDURE; Name: Prolonged Exposure; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Present Centered Therapy; Assigned to Arm(s): 2
C: Arm Label: Lifespan Integration; Type: EXPERIMENTAL; Interventions: Other: Lifespan Integration | Arm Label: Waiting list; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Lifespan Integration; Assigned to Arm(s): Lifespan Integration
D: Arm Label: Motivational Interviewing; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Interviewing | Arm Label: MI with trauma-informed SGM affirmative care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Trauma-informed SGM affirmative care | Intervention Type: BEHAVIORAL; Name: Trauma-informed SGM affirmative care; Assigned to Arm(s): MI with trauma-informed SGM affirmative care | Intervention Type: BEHAVIORAL; Name: Motivational Interviewing; Assigned to Arm(s): Motivational Interviewing

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Immunization Schedule Alert Platform: Determining ISAP SMS Efficacy in Improving Childhood Immunization Timeliness and Completeness in Nigeria
Brief Summary: The ISAP study is investigating the efficacy of SMS messages in improving routine childhood Immunization timeliness and completeness in Nigeria.


Options:
A: Arm Label: Clinic group 1; Type: EXPERIMENTAL; Interventions: Behavioral: mHealth messaging | Arm Label: Clinic group 2; Type: EXPERIMENTAL; Interventions: Behavioral: Transport Payments | Arm Label: Clinic group 3; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: mHealth messaging; Assigned to Arm(s): Clinic group 1 | Intervention Type: BEHAVIORAL; Name: Transport Payments; Assigned to Arm(s): Clinic group 2
B: Arm Label: Smartphone-enabled app for linkage to care; Type: EXPERIMENTAL; Interventions: Other: Smartphone application, Device: Smartphone | Arm Label: Standard of care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Smartphone application; Assigned to Arm(s): Smartphone-enabled app for linkage to care | Intervention Type: DEVICE; Name: Smartphone; Assigned to Arm(s): Smartphone-enabled app for linkage to care
C: Arm Label: ISAP SMS; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: ISAP SMS | Arm Label: No ISAP SMS; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ISAP SMS; Assigned to Arm(s): ISAP SMS
D: Arm Label: LATCH Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: LATCH Intervention | Intervention Type: BEHAVIORAL; Name: LATCH Intervention; Assigned to Arm(s): LATCH Intervention

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Immunization Schedule Alert Platform: Determining ISAP SMS Efficacy in Improving Childhood Immunization Timeliness and Completeness in Nigeria
Brief Summary: The ISAP study is investigating the efficacy of SMS messages in improving routine childhood Immunization timeliness and completeness in Nigeria.


Options:
A: Arm Label: Text message vaccine reminders; Type: EXPERIMENTAL; Interventions: Other: Text Message, Other: automated call | Arm Label: automated phone call from clinic; Type: ACTIVE_COMPARATOR; Interventions: Other: automated call | Intervention Type: OTHER; Name: Text Message; Assigned to Arm(s): Text message vaccine reminders | Intervention Type: OTHER; Name: automated call; Assigned to Arm(s): Text message vaccine reminders, automated phone call from clinic
B: Arm Label: ISAP SMS; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: ISAP SMS | Arm Label: No ISAP SMS; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ISAP SMS; Assigned to Arm(s): ISAP SMS
C: Arm Label: Telephone reminder; Type: EXPERIMENTAL; Interventions: Other: Telephone reminder | Arm Label: Text Message reminder; Type: EXPERIMENTAL; Interventions: Other: Text Message reminder | Arm Label: Control: Telephone; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Control: Text Message; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Telephone reminder; Assigned to Arm(s): Telephone reminder | Intervention Type: OTHER; Name: Text Message reminder; Assigned to Arm(s): Text Message reminder
D: Arm Label: Text and Voice Messages; Type: EXPERIMENTAL; Interventions: Behavioral: Text and Voice Messages | Arm Label: Interactive Phone Call; Type: EXPERIMENTAL; Interventions: Behavioral: Interactive Phone Call | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Text and Voice Messages; Assigned to Arm(s): Text and Voice Messages | Intervention Type: BEHAVIORAL; Name: Interactive Phone Call; Assigned to Arm(s): Interactive Phone Call

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Immunization Schedule Alert Platform: Determining ISAP SMS Efficacy in Improving Childhood Immunization Timeliness and Completeness in Nigeria
Brief Summary: The ISAP study is investigating the efficacy of SMS messages in improving routine childhood Immunization timeliness and completeness in Nigeria.


Options:
A: Arm Label: ISAP SMS; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: ISAP SMS | Arm Label: No ISAP SMS; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ISAP SMS; Assigned to Arm(s): ISAP SMS
B: Arm Label: Weekly SMS, brief message; Type: EXPERIMENTAL; Interventions: Behavioral: Short Message Services to Support ARV therapy adherence | Arm Label: Control Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Short Message Services to Support ARV therapy adherence | Arm Label: Daily SMS, Brief message; Type: EXPERIMENTAL; Interventions: Behavioral: Short Message Services to Support ARV therapy adherence | Arm Label: Daily SMS, Long Message; Type: EXPERIMENTAL; Interventions: Behavioral: Short Message Services to Support ARV therapy adherence | Arm Label: Weekly SMS, Long Message; Type: EXPERIMENTAL; Interventions: Behavioral: Short Message Services to Support ARV therapy adherence | Intervention Type: BEHAVIORAL; Name: Short Message Services to Support ARV therapy adherence; Assigned to Arm(s): Control Group, Daily SMS, Brief message, Daily SMS, Long Message, Weekly SMS, Long Message, Weekly SMS, brief message
C: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: EpxBreastfeeding, Other: Baby book survey | Arm Label: Control; Type: OTHER; Interventions: Other: Baby book survey | Intervention Type: OTHER; Name: EpxBreastfeeding; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Baby book survey; Assigned to Arm(s): Control, Intervention
D: Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Other: Print brochure | Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: mMammogram | Intervention Type: BEHAVIORAL; Name: mMammogram; Assigned to Arm(s): Intervention group | Intervention Type: OTHER; Name: Print brochure; Assigned to Arm(s): Control group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Immunization Schedule Alert Platform: Determining ISAP SMS Efficacy in Improving Childhood Immunization Timeliness and Completeness in Nigeria
Brief Summary: The ISAP study is investigating the efficacy of SMS messages in improving routine childhood Immunization timeliness and completeness in Nigeria.


Options:
A: Arm Label: Text and Voice Messages; Type: EXPERIMENTAL; Interventions: Behavioral: Text and Voice Messages | Arm Label: Interactive Phone Call; Type: EXPERIMENTAL; Interventions: Behavioral: Interactive Phone Call | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Text and Voice Messages; Assigned to Arm(s): Text and Voice Messages | Intervention Type: BEHAVIORAL; Name: Interactive Phone Call; Assigned to Arm(s): Interactive Phone Call
B: Arm Label: ISAP SMS; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: ISAP SMS | Arm Label: No ISAP SMS; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ISAP SMS; Assigned to Arm(s): ISAP SMS
C: Arm Label: SmartMoms-Clinic; Type: EXPERIMENTAL; Interventions: Behavioral: SmartMoms | Arm Label: SmartMoms-Phone; Type: EXPERIMENTAL; Interventions: Behavioral: SmartMoms | Arm Label: Physician Directed; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: SmartMoms; Assigned to Arm(s): SmartMoms-Clinic, SmartMoms-Phone
D: Arm Label: cMM and Text Messaging; Type: OTHER; Interventions: Behavioral: cMM, Behavioral: Text Messaging | Arm Label: cMM Only; Type: OTHER; Interventions: Behavioral: cMM | Arm Label: Text Messaging Only; Type: OTHER; Interventions: Behavioral: Text Messaging | Arm Label: Neither cMM nor Text Messaging; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: cMM; Assigned to Arm(s): cMM Only, cMM and Text Messaging | Intervention Type: BEHAVIORAL; Name: Text Messaging; Assigned to Arm(s): Text Messaging Only, cMM and Text Messaging

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Immunization Schedule Alert Platform: Determining ISAP SMS Efficacy in Improving Childhood Immunization Timeliness and Completeness in Nigeria
Brief Summary: The ISAP study is investigating the efficacy of SMS messages in improving routine childhood Immunization timeliness and completeness in Nigeria.


Options:
A: Arm Label: Control; Type: N/A; Interventions: Behavioral: Control | Arm Label: Intervention; Type: N/A; Interventions: Behavioral: Intervention | Intervention Type: BEHAVIORAL; Name: Control; Assigned to Arm(s): Control | Intervention Type: BEHAVIORAL; Name: Intervention; Assigned to Arm(s): Intervention
B: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Quit4Baby, Behavioral: Text4Baby | Arm Label: Control; Type: OTHER; Interventions: Behavioral: Text4Baby | Intervention Type: BEHAVIORAL; Name: Quit4Baby; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Text4Baby; Assigned to Arm(s): Control, Intervention
C: Arm Label: ISAP SMS; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: ISAP SMS | Arm Label: No ISAP SMS; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ISAP SMS; Assigned to Arm(s): ISAP SMS
D: Arm Label: ARM 1 = TEXT MESSAGING SUPPORT; Type: EXPERIMENTAL; Interventions: Drug: nPEP, Behavioral: Text Messaging Support | Arm Label: ARM 2 = NO TEXT MESSAGING SUPPORT; Type: EXPERIMENTAL; Interventions: Drug: nPEP | Arm Label: ARM 3 = NURSE-LED nPEP; Type: EXPERIMENTAL; Interventions: Drug: nPEP, Other: Nurse-Led nPEP | Arm Label: ARM 4 = ID PHYSICIAN-LED nPEP,; Type: ACTIVE_COMPARATOR; Interventions: Drug: nPEP | Intervention Type: DRUG; Name: nPEP; Assigned to Arm(s): ARM 1 = TEXT MESSAGING SUPPORT, ARM 2 = NO TEXT MESSAGING SUPPORT, ARM 3 = NURSE-LED nPEP, ARM 4 = ID PHYSICIAN-LED nPEP, | Intervention Type: BEHAVIORAL; Name: Text Messaging Support; Assigned to Arm(s): ARM 1 = TEXT MESSAGING SUPPORT | Intervention Type: OTHER; Name: Nurse-Led nPEP; Assigned to Arm(s): ARM 3 = NURSE-LED nPEP

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Feasibility Randomised Controlled Study of an Innovative Postnatal Breastfeeding Peer Counselling Programme
Brief Summary: A feasibility study is proposed in the current study as women who had given birth to their first babies recruited to a previous project specifically expressed the need for postnatal breastfeeding support from peer counsellors at home and there is evidence that this could be of benefit for women and their infants. Evidence of whether women in Hong Kong who had peer counsellors have better breastfeeding outcomes compared to women who had standard care however is not available. Prior to undertaking a definitive trial, the investigators need to know if women would be willing to be recruited and randomised to an intervention or standard care.


Options:
A: Arm Label: Community behaviour change campaign; Type: EXPERIMENTAL; Interventions: Behavioral: Community behaviour change campaign | Arm Label: No community behaviour change campaign; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Community behaviour change campaign; Assigned to Arm(s): Community behaviour change campaign
B: Arm Label: A&T- intensive; Type: EXPERIMENTAL; Interventions: Behavioral: Maternal Nutrition Behavior change | Arm Label: A&T-non intensive; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Maternal Nutrition Behavior change; Assigned to Arm(s): A&T- intensive
C: Arm Label: Home-based peer counselling intervention; Type: ACTIVE_COMPARATOR; Interventions: Other: Home-based peer counselling (web-based) intervention | Arm Label: Standard usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Home-based peer counselling (web-based) intervention; Assigned to Arm(s): Home-based peer counselling intervention
D: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Relaxation; Type: EXPERIMENTAL; Interventions: Behavioral: Relaxation | Intervention Type: BEHAVIORAL; Name: Relaxation; Assigned to Arm(s): Relaxation

Answer: C